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Accepted 21 December 2009The placenta is adherent to the endometrial lining in normal
pregnancies. Penetration beyond this is abnormal and is
categorized according to the depth of invasion [1].
The frequency of abnormal placentation varies between 1 in
333 and 1 in 70,000 births with a mean incidence of 1 in 2,500
births [2]. The incidence of placenta accreta has dramatically
increased in recent years, which can be attributed to increasing
caesarean rate in most countries [3]. The risk factors include
a history of placenta previa, caesarean section, dilation and
curettage, previous myomectomy, multiparity, elevated maternal
age (>35), and erythroblastosis fetalis [4].
Several therapeutic methods are described for placenta
accreta, including immediate hysterectomy after delivery,
leaving the placenta in site after delivery, methotrexate (MTX)
administration, uterine artery embolization, and temporary
occlusion of internal iliac artery. In any given case, one or more
of these techniques may be used to minimize hemorrhage [1].
In this case report, we are introducing a multidisciplinary
approach, which led to uterine preservation. The main purpose
of this study was to prove that there is no contraindication in
using several methods simultaneously; and if indicated, we can
use them together.
The patient was a 23-year-old primigravid woman without
previous history of uterine surgery or curettage. She was on
methyldopa to control her chronic hypertension. Placenta did
not expel after normal vaginal delivery of her term pregnancy;
however, the patients’ vital signs were stable. The patient was
taken to the theatre for manual removal of placenta using
forceps. Only a small part of the placenta was extracted. After
the procedure, she had severe vaginal bleeding (around 700 cc)* Corresponding author. Maternal- Fetal - Neonatal Health Research Centre,
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hemorrhage was partially controlled with five rectal miso-
prostol tablets. The patient was then hemodynamically stable
but still had mild vaginal bleeding. Early gray scale and
Doppler sonography (Siemens, Sonoline Anthares, Germany)
showed bicornuate uterus (which had not been previously
diagnosed), myometrium thinning at placental implantation
site in fundus, and periplacental hypervascularity suggestive of
placenta accreta. Magnetic resonance imaging (GE, Signa
1.5 T, USA) also revealed bicornuate uterus and clear signs
of placenta accreta and retained placenta with thinning of
surrounding myometrium in its left cornua (Fig. 1, 2). Only
mild anemia was noted on laboratory data, whereas FDP,
D-dimer, and b-HCG titre were all normal. The patient did not
convince about hysterectomy what so ever, so she was kept
under close observation in the emergency ward because fatal
complications were probable.
She was quite stable during the first week after delivery and
placenta was not expelled. A single dose MTX (50 mg intra-
muscular) was administered 1 week after the NVD. Three days
later, the patient expelled a small part of placenta, which was
confirmed by pathology and seemed to be the injured part of the
placenta during the try for manual removal. Afterward, vaginal
bleeding decreased significantly; but as far as it did not cease
completely, sonography revealed remained placenta and the
patient still insisted on preserving her uterus, she became candi-
date for uterine artery embolization a week after MTX adminis-
tration. After prophylactic cephazoline 1 g intravenous injection,
under local anesthesia and via right transfemoral access, both
uterine arteries were selectively catheterized under fluoroscopic
guide. Digital subtraction angiography (GE, Innova 4200, USA)
showed placental blush and enlarged uterine arteries, which were
embolized on both sides with one vial of 250e355 PVA (Poly
vinyl alcohol) and 1 vial of 350-500 m PVA (Fig. 3A, B; Fig. 4A,cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) and (B) Gray scale and Doppler sonography shows myometrium thinning at placental implantation site in fundus (arrow), and periplacental
hypervascularity.
Fig. 2. Magnetic resonance imaging reveals bicornuate uterus (arrow) and
retained placenta with thinning of surrounding myometrium (arrow heads) in
its left cornua on (A) axial and (B) sagittal images.
115S. Hantoushzadeh et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 114e117B). The patient had pain and tenderness on her uterus and low-
grade fever (38e39 C) after embolization,whichwas acceptable
for the first 24 hours as postembolization syndrome, but the fever
did not subside and attained up to 40Cwithin 4 days. High-grade
fever in combination with leukocytosis and neutrophilia on serial
CBCs, elevated ESR (137e139) and CRPþ3 were suggestive of
infection in the retained placenta. The patient received broad-
spectrum antibiotics (ceftriaxone in combination with clinda-
mycin and gentamycin) and became candidate for hysterotomy.
Hysterotomy was performed via a 2-cm horizontal incision in
lower segment of uterus. The accreta placenta was obviously
found in the endometrial cavity of one of uterine horns. Owing to
previous MTX administration and embolization, placenta could
be removed easily without much bleeding and the amount of
hemorrhage from uterus incision was scant (4e5 cc) because of
previous embolization procedure. Some necrotic and malodour
tissues were found behind the placenta and removed completely.
Following the surgery, antibiotic regimen continued for 14 days
(after 48 hours, the patient became afebrile); and meanwhile, the
leukocyte count decreased to normal (see Table 1). The patient
was discharged in good general condition without vaginal
bleeding while her uterus and fertility was preserved. During
follow up visits within 6 months, the patient mentioned regular
menstruation without abnormal vaginal bleeding.
Abnormal adherence of placenta to the uterine wall
“placenta accreta” is a rare complication of pregnancy that is
associated with high morbidity and mortality from severe
bleeding and infection of retained placenta [5].
Despite the presence of risk factors, placenta accreta is
usually diagnosed after delivery when spontaneous and manual
removal of placenta fails. In our case, bicornuate uterus and its
associated vascularization defect are the possible risk factors,
although this condition is less common than other known risk
factors [6,7].
The standard treatment of placenta accreta consists of either
surgical nonconservative approach with primary total hyster-
ectomy or extirpative approach with only resection and extrac-
tion of placenta. In cases of life-threatening vaginal bleeding,
immediate hysterectomy is always indicated. If conservative
management is desired, extirpative maneuvers to remove theplacenta and partial placental resections are performed to
minimize placental size. Persistent excessive bleeding after
conservative management necessitates hysterectomy. Addi-
tional treatments for initial management include arterial
Fig. 3. (A) and (B) Digital subtraction angiography shows placental blush and enlarged uterine arteries (arrow), which are embolized on both sides with Polyvinyl
alcohol.
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Using a single dose of 50 mg MTX in immediate postpartum
period helps to enhance placental lyses and it reduces size of the
remaining placenta. Uterine artery embolization is currently
a well-recognized alternative treatment in conservative
management after failure of or in conjunction with local and
medical treatments, preventing the morbidity of hysterectomy
and preserving potential of fertility. If severe acute haemorrhage
occurs secondly to placental detachment, embolization will
reduce its severity. The choice of conservative management or
hysterectomy is based on patient’s medical history with respect
to maternal age and desire for future pregnancy, severity of
bleeding and hemodynamic status of the patient [8].
In this patient, conservative management was considered
because of young maternal age, desire for preserving fertility
and primary haemodynamic stability and scant vaginal
bleeding. After attempt to manual removal of placenta and
MTX administration, parts of placenta remained in uterus and
bleeding did not stop completely, so uterine artery emboliza-
tion was undertaken for two main goals: decreasing the life-
threating emergent bleeding and may be facilitating placental
lyses with reduction in its vascularisation [9]. Embolization of
the uterine arteries is currently a well recognized alternative
treatment in the conservative management of postpartumTable 1
WBC count in different times of therapy
Time WBC count PMN (%)
Methotrexate therapy 13,760 84
Embolization 12,699 83
Hysterotomy 7,960 77
Discharge 6,900 71
WBC ¼ white blood cell; PMN ¼ polymorphonuclear leukocyte.haemorrhage after the failure of or in association with local
and medical treatment, thus avoiding the morbidity associated
with hysterectomy and preserving potential fertility [9].
Although the patient underwent hysterotomy due to infection
of retained parts of placenta (high fever with purulent cervical
discharge are sign s of infected retained products of pregnancy)
that was manifested as high fever and signs of sepsis, placental
removal was easy and bleeding at site of incision was minimal.
Therefore we find that there is no contraindication in using
several methods simultaneously and if indicated, we can use
them together. As mentioned, different conservative manage-
ments were used in our case and finally she was discharged in
good condition while saving her uterus. Awareness of rare
complications of pregnancy and knowledge towards their
diagnostic and therapeutic methods in prenatal period brings
better quality of life for mothers. Further investigations on
approaches which can save mothers’ uterus and fertility in
placenta accreta are highly fostered.References
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